miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN

(2012) Boning Liu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells

(2012) Weiguang Li et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The pathological roles of BART miRNAs in nasopharyngeal carcinoma

(2012) Angela K-F Lo et al.   JOURNAL OF PATHOLOGY

MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells

(2012) Xiaomin Dang et al.   Cancer Genetics

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma

(2011) Min Deng et al.   JOURNAL OF CELL SCIENCE

EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin

(2011) Z-T Tong et al.   ONCOGENE

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98

(2011) N M Alajez et al.   Cell Death & Disease

MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells

(2010) Gang Li et al.   CANCER LETTERS

MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression

(2010) Thian-Sze Wong et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MicroRNAs in Cancer

(2008) Yong Sun Lee et al.   Annual Review of Pathology-Mechanisms of Disease